ReviewPharmacological reports : PR2020
Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance.
Swastika Maity et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papercites it